학술논문

The analysis of gut microbiota in patients with bile acid diarrhoea treated with colesevelam
Document Type
article
Source
Frontiers in Microbiology, Vol 14 (2023)
Subject
microbiome
Crohn’s disease
bile acid diarrhoea
colesevelam
post-cholecystectomy
Microbiology
QR1-502
Language
English
ISSN
1664-302X
40927458
Abstract
IntroductionBile acid diarrhoea (BAD) is a common disorder that results from an increased loss of primary bile acids and can result in a change in microbiome. The aims of this study were to characterise the microbiome in different cohorts of patients with BAD and to determine if treatment with a bile acid sequestrant, colesevelam, can alter the microbiome and improve microbial diversity.Materials and methodsPatients with symptoms of diarrhoea underwent 75-selenium homocholic acid (75SeHCAT) testing and were categorised into four cohorts: idiopathic BAD, post-cholecystectomy BAD, post-operative Crohn’s disease BAD and 75SeHCAT negative control group. Patients with a positive 75SeHCAT (